NO146775C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive racemiske eller optisk aktive kondenserte pyrimidinderivater - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive racemiske eller optisk aktive kondenserte pyrimidinderivater

Info

Publication number
NO146775C
NO146775C NO770457A NO770457A NO146775C NO 146775 C NO146775 C NO 146775C NO 770457 A NO770457 A NO 770457A NO 770457 A NO770457 A NO 770457A NO 146775 C NO146775 C NO 146775C
Authority
NO
Norway
Prior art keywords
active
preparation
pyrimidine derivatives
racemic
optic
Prior art date
Application number
NO770457A
Other languages
English (en)
Norwegian (no)
Other versions
NO146775B (no
NO770457L (no
Inventor
Istvan Hermecz
Zoltan Meszaros
Sador Virag
Lelle Vasvari
Agnes Horvath
Jozsef Knoll
Gyula Sebestyen
Agoston David
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of NO770457L publication Critical patent/NO770457L/no
Publication of NO146775B publication Critical patent/NO146775B/no
Publication of NO146775C publication Critical patent/NO146775C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO770457A 1976-02-12 1977-02-11 Analogifremgangsmaate ved fremstilling av terapeutisk aktive racemiske eller optisk aktive kondenserte pyrimidinderivater NO146775C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU76CI1642A HU174693B (hu) 1976-02-12 1976-02-12 Sposob poluchenija kondensirovannykh proizvodnykh pirimidina

Publications (3)

Publication Number Publication Date
NO770457L NO770457L (no) 1977-08-15
NO146775B NO146775B (no) 1982-08-30
NO146775C true NO146775C (no) 1982-12-08

Family

ID=10994601

Family Applications (1)

Application Number Title Priority Date Filing Date
NO770457A NO146775C (no) 1976-02-12 1977-02-11 Analogifremgangsmaate ved fremstilling av terapeutisk aktive racemiske eller optisk aktive kondenserte pyrimidinderivater

Country Status (28)

Country Link
US (2) US4123533A (de)
JP (1) JPS5297996A (de)
AR (1) AR220675A1 (de)
AT (1) AT357539B (de)
AU (1) AU512470B2 (de)
BE (1) BE851346A (de)
BG (1) BG29723A3 (de)
CA (1) CA1082699A (de)
CH (1) CH637651A5 (de)
CS (1) CS199288B2 (de)
DD (1) DD131557A5 (de)
DE (1) DE2705778A1 (de)
DK (1) DK152431C (de)
ES (1) ES455800A1 (de)
FI (1) FI63574C (de)
FR (1) FR2340945A1 (de)
GB (1) GB1554370A (de)
GR (1) GR62466B (de)
HU (1) HU174693B (de)
IL (1) IL51388A (de)
IN (1) IN146173B (de)
NL (1) NL7701461A (de)
NO (1) NO146775C (de)
PL (1) PL109346B1 (de)
PT (1) PT66184B (de)
SE (1) SE431334B (de)
SU (1) SU969165A3 (de)
YU (1) YU33777A (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU173438B (hu) * 1975-11-27 1979-05-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom
HU185925B (en) * 1977-12-29 1985-04-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing compounds with nitrogen bridge head
HU180439B (en) * 1977-12-29 1983-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 9-amino-pyrido-square bracket-1,2-a-square bracket closed-pyrimidine derivatives
HU180701B (en) * 1977-12-29 1983-04-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing pyrido-/1,2-a/pyrimidines containing a carboxylic or ester group on the pirimidimering
HU178496B (en) * 1977-12-29 1982-05-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing 6,7,8,9-tetrahydro-4h-pyrido/1,2-a/pyrimidine derivatives with antiallergic activity
HU184058B (en) * 1977-12-29 1984-06-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing new compounds with nitrogen bridge head
US4642384A (en) * 1979-03-19 1987-02-10 Riker Laboratories, Inc. Process for the preparation of derivatives of pyrrolidine and piperidine
AT370731B (de) * 1979-05-02 1983-04-25 Chinoin Gyogyszer Es Vegyeszet Verfahren zur herstellung von neuen kondensierten pyrimidin-derivaten sowie von deren optischen antipoden und salzen
HU183408B (en) * 1981-04-28 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing oral ratard pharmaceutical compositions
AT377586B (de) 1981-06-30 1985-04-10 Erba Farmitalia Verfahren zur herstellung von substituierten pyrrolo-(2,1-b)-chinazolinen und pyrido(2,1-b)chinazolinen
ES8406476A1 (es) * 1982-04-29 1984-07-01 Erba Farmitalia Procedimiento para preparar derivados cicloalifaticos condensados de pirido(1,2-a)pirimidinas sustituidas.
IL69274A (en) * 1982-08-05 1986-08-31 Erba Farmitalia (substituted amino)derivatives of 3-benzylidene-pyrrolo(2,1-b)quinazolin-9-ones and 6-benzylidene-pyrido(2,1-b)quinazolin-11-ones,their preparation and pharmaceutical compositions containing them
US5252572A (en) * 1988-02-03 1993-10-12 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt. Pyridopyrimidine derivatives, pharmaceutical compositions containing them and process for preparing same
EP1539762A2 (de) * 2002-06-26 2005-06-15 Bristol-Myers Squibb Company Bicyclische pyrimidinone als inhibitoren der koagulationskaskade

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3376304A (en) * 1962-03-14 1968-04-02 Mcneilab Inc 2-(r-r1-r2-methyl)-6-r3-6-r4-fulvenes
US3907798A (en) * 1966-06-15 1975-09-23 Sterling Drug Inc Preparation of 4H-pyrido{8 1,2-a{9 pyrimidin-4-ones from cyclic alkylidene 2-pyridylaminomethylenemalonates
AT286990B (de) * 1966-11-02 1971-01-11 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von neuen Homopyrimidazol-Derivaten sowie von deren Salzen
US3567719A (en) * 1967-05-17 1971-03-02 Eastman Kodak Co Methods for preparing dyes and novel dye intermediates
US3635956A (en) * 1968-03-01 1972-01-18 Squibb & Sons Inc Benzothiazines related compounds derivatives and salts thereof
FR2187311B1 (de) * 1972-06-02 1975-06-20 Bouchara Emile
HU168014B (de) * 1973-03-30 1976-02-28
US3897420A (en) * 1973-06-28 1975-07-29 Squibb & Sons Inc 2-Aminoalkyl-7-substituted-3,3a,4,5,6,7-hexahydro-3-substituted-2H-pyrazolo(4,3-c)pyridines
US3929787A (en) * 1974-04-22 1975-12-30 Squibb & Sons Inc 6,7,8,9-Tetrahydro-pyrido(1,2-a)pyrimidin-4-ones
DE2427614A1 (de) * 1974-06-07 1976-01-02 Gruenenthal Chemie Neue pyrrolderivate und verfahren zu ihrer herstellung
US3898224A (en) * 1974-09-09 1975-08-05 Squibb & Sons Inc 1,6,7,8-Tetrahydro-4-oxo-4H-pyrido {8 1,2-A{9 pyrimidine-9-carboalkoxy compounds
US3965100A (en) * 1975-02-26 1976-06-22 E. R. Squibb & Sons, Inc. 2,3-Dihydrocyclopenta[d]pyrido[1,2-a]pyrimidin-10(1H)-one and its derivatives
US3935197A (en) * 1975-05-16 1976-01-27 E. R. Squibb & Sons, Inc. 2-Styryl-4H-pyrido(1,2-a)pyrimidin-4-ones

Also Published As

Publication number Publication date
PT66184A (pt) 1977-03-01
SE431334B (sv) 1984-01-30
DD131557A5 (de) 1978-07-05
FI63574C (fi) 1983-07-11
CH637651A5 (de) 1983-08-15
FR2340945B1 (de) 1981-11-27
IL51388A0 (en) 1977-04-29
NL7701461A (nl) 1977-08-16
US4252807A (en) 1981-02-24
JPS5297996A (en) 1977-08-17
ES455800A1 (es) 1978-07-01
AR220675A1 (es) 1980-11-28
BE851346A (fr) 1977-05-31
BG29723A3 (en) 1981-01-15
IL51388A (en) 1981-07-31
PT66184B (pt) 1978-07-11
DE2705778C2 (de) 1990-11-29
FI63574B (fi) 1983-03-31
DK152431C (da) 1988-08-01
YU33777A (en) 1983-02-28
SE7701375L (sv) 1977-08-13
HU174693B (hu) 1980-03-28
DE2705778A1 (de) 1977-08-18
JPS6228793B2 (de) 1987-06-23
US4123533A (en) 1978-10-31
FI770453A (de) 1977-08-13
PL109346B1 (en) 1980-05-31
FR2340945A1 (fr) 1977-09-09
CA1082699A (en) 1980-07-29
AU512470B2 (en) 1980-10-16
SU969165A3 (ru) 1982-10-23
IN146173B (de) 1979-03-10
DK152431B (da) 1988-02-29
GR62466B (en) 1979-04-13
AT357539B (de) 1980-07-10
NO146775B (no) 1982-08-30
DK59177A (da) 1977-08-13
CS199288B2 (en) 1980-07-31
NO770457L (no) 1977-08-15
AU2217277A (en) 1978-08-17
ATA84277A (de) 1979-12-15
GB1554370A (en) 1979-10-17

Similar Documents

Publication Publication Date Title
NO149962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO800858L (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-amino-3-kinolincarboxylsyrederivater
NO151463C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO151588C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamid-derivater
NO151546C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidoner
NO153135C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme n-(fenoksyalkyl)-imidazolderivater.
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO147560C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive indanyl-derivater
NO800881L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
NO146775C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive racemiske eller optisk aktive kondenserte pyrimidinderivater
NO149312C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 2-(2-tenoyltio)-propionylglycin
NO147953C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglukosider
NO784393L (no) Fremgangsmaate ved fremstilling av anti-allergisk aktive pyrimidin-derivater
NO148777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater
NO145236C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive omega-aminocarboxylsyrederivater
NO149737C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-azaxanthon-3-carboxylsyrer
NO152089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-pyridon-3-karboksylsyrederivater
NO151285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO150158C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6,7-dimetoksyquinazolinderivater
NO148452C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-fenyl-1-propanol-derivater
NO149960C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive bis(nitrosoureido)-polyolderivater
NO152172C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
NO147273C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive cykloheksadien-derivater
NO152839C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.